IU announces first round of funding for $300 million Grand Challenges Program
IU has announced that the Precision Health Initiative, a research initiative focused on patient-centered precision medicine therapies, is the first recipient of funding under the university’s new $300 millionGrand Challenges Program.
Led by faculty at the IU School of Medicine, IU Bloomington and IUPUI, the Precision Health Initiative will develop IU's expertise in individualized precision medicine. Precision Health Initiative team members will work closely with several prominent business and community partners, including Eli Lilly and Co., Roche Diagnostics, Cook Regentec, Deloitte, Regenstrief Institute and IU Health. The primary goals will be to transform health care for the people of Indiana and medical research and education at IU.